Concepedia

Jonas A. Gylys

JA

14

Publications

469

Citations

12

H-Index

1962

Active since

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Jonas A. Gylys is an author at Bristol-Myers Squibb (Germany) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1962–1993

14

Publications

14

The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.

Anthony W. Pircio, Jonas A. Gylys, R L Cavanagh et al. · PubMed · 1976 · 144 citations

, , +13

Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats

Hugh A. Tilson, J. Chamberlain, Jonas A. Gylys et al. · European Journal of Pharmacology · 1977 · 54 citations

, , +5

BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.

Jonas A. Gylys, Rachael Wright, W D Nicolosi et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 42 citations

Phenylalkylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane

Robert T. Standridge, Henry G. Howell, Jonas A. Gylys et al. · Journal of Medicinal Chemistry · 1976 · 38 citations

, , +17

Antitussive properties of butorphanol.

R L Cavanagh, Jonas A. Gylys, M. E. Bierwagen · PubMed · 1976 · 33 citations

, , +11

Rows per page

1–5 of 14